Similarly, HuR and AGAP2-AS interact and stabilize CPT1A (Carnitine Palmitoyltransferase 1A) in mesenchymal stem cells, thereby promoting trastuzumab resistance in breast cancer [136]. This evidence concerns the gene ELAVL1 and breast carcinoma.